Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics

Ultima Genomics adds tenured leadership to drive operational excellence and commercial adoption

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities

Ultima Genomics Adds Former Thermo Fisher Exec Mark Stevenson to Board of Directors

Hartwig and Ultima Genomics Collaborate to Reduce Costs for Whole Genome Cancer Profiling, Minimal Residual Disease Testing and Generating Genetic Data at Scale

The $100 Genome: Visiting Ultima Genomics and seeing the UG 100 sequencer

Fluent BioSciences awarded NIH SBIR grant to commercialize low-cost million-cell transcriptome profiling kits powered by Ultima Genomics sequencing, prototype kits now shipping

Ultima Announces UG 100™ and Reveals Disruptive Cost and Accuracy Profile to Enable the Era of the $100 Genome and Beyond

Ultima Genomics to Launch UG 100™ System and Present Data at AGBT

Ultima Genomics Announces End of Early Access and Upcoming Launch of UG 100™

Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing

Ultima Genomics to Present at ASHG and Provide Updated Reference Data Set

Integrated DNA Technologies Reveals Launch of xGen™ Products for Ultima Genomics®

Newly Funded NIH Genome Characterization Centers Aim to Elucidate Human Somatic Mosaicism

Ultima Genomics Adds Tenured Strategic and Technology Leadership In Preparation for Commercial Launch

Ultima Genomics and Genome Insight Collaborate to Bring Affordable Whole Genome Sequencing to Cancer Patients

Ultima Genomics named #1 on Fast Company’s list of the most innovative biotech companies of 2023

The $100 genome has been a biotech holy grail for decades. This company made it a reality

cfDNA Methylation Profiling Shows Promise as Blood Biomarker for Congestive Heart Failure

Ultima Genomics and Integrated DNA Technologies to Enable Application Portfolio on Ultima Sequencing Platforms

Ultima Genomics Partners with New England Biolabs® to Expand Research Applications on Ultima Sequencers

Ultima Genomics Announces Collaboration with 10x Genomics to Enable Seamless Integration of Chromium Single Cell Applications on Ultima Sequencers

NY Genome Center Team Harnesses Ultima Genomics Platform for High-Sensitivity ctDNA Sequencing

Can Start-Ups Significantly Lower the Cost of Gene Sequencing?

Ultima Genomics signs development agreement with Regeneron aimed at driving the scale of genomic information for drug discovery and development

Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to genomic testing by driving down sequencing costs

Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics

Ultima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated Computing

Ultima Genomics partners with Sentieon and Google DeepVariant to deliver high-performance variant calling

Andreessen, Founders Fund Back Genomics Startup Exiting Stealth

Ultima Genomics claims $100 full genome sequencing after stealth $600M raise

Ultima Genomics Delivers the $100 Genome

Join us at ASHG 2024! - Download our comprehensive Ultima Genomics program guide

Festival of Genomics Boston 2024

AACR 2024 - See how the UG 100™ is being used to advance oncology research

AGBT 2024 - Witness the launch of the UG 100™ platform enabling the $100 genome

ASHG 2023 - See the new standard reference Genome-in-a-Bottle (GIAB) data to be presented and published at this year's ASHG conference November 1 - 5

AACR 2023 - See how our collaborators are applying genomics at scale in oncology

AGBT 2023 - Learn how our collaborators are demonstrating the power of genomics at scale at AGBT 2023

ASHG 2022 - See the data our collaborators will present at this year's ASHG conference October 25-29

AGBT 2022 - Ultima Genomics is unleashing the power of genomics at scale